cigna glp-1 coverage news today Health insurer will stop covering weight loss drugs in its employee health plan Why Cigna is capping cost

The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide established injection as the delivery method with the strongest clinical backing

Nonetheless, a recent review including rodent studies supports the notion that GLP-1 has differential effects before compared to after a meal (Decarie-Spain & Kanoski, 2021)

The smart expansion play is to broaden access to branded, FDA-approved options (injectable and oral GLP-1s), integrate with manufacturer direct channels like LillyDirect and NovoCare, and deepen the services that pure fulfillment can't match: prior authorization and denial-appeal support, employer-benefit syncing to find patients their lowest out-of-pocket cost, nutrition and coaching, and maintenance pathways

What results can I realistically expect given my specific situation

Furthermore, Gier et al